StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SVRASavara Inc
stockpulse.co.kr
Nasdaq
$4.26▲ 1.31%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $873.0MShares out 200M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

4
  • 9.25After-hours26.09.26 08:01
    4Ownership#●●●

    Savara Inc

    Braden Parker of Savara Inc. executed a Limited Power of Attorney on September 10, 2026, to facilitate compliance with Section 16(a) reporting requirements under the Securities Exchange Act. This grants the company's Chief Operating & Financial Officer and Chief Legal Officer the authority to act on his behalf regarding equity security transaction filings.…more

    $4.26+1.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 8.11After-hours26.08.12 06:11
    S-8Offering

    Savara Inc

    Savara Inc.는 '2024 Omnibus Incentive Plan'에 따라 보통주 1,890만 주를 추가로 발행하기 위해 Form S-8 등록 신고서를 제출했습니다. 이번 신주 발행은 임직원 대상 주식 보상 계획의 일환으로 진행되며, 주식 수 증가에 따른 기존 주주 지분 희석이 발생합니다.…more

    $4.26+1.31%vs prev close
    View filingShare
  • 8.11After-hours26.08.12 05:05
    10-QEarnings

    Savara Inc

    사바라(Savara Inc.)는 2026년 6월 30일 기준 분기 보고서를 통해 발행 주식 총수를 6억 주까지 확대하는 정관 변경을 확정했습니다. 2026년 2분기 기준 현금 및 단기 투자 자산은 총 1억 7,303만 달러이며, 연구개발비 증가 등으로 인해 전년 동기 대비 운영 비용이 확대되었습니다.…more

    $4.26+1.31%vs prev close
    View filingShare

3 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 3d agoRegular26.10.22 02:13
    #●●●#●●●

    Savara Presents Molgramostim Clinical Analysis at CHEST 2026

    Savara presented a post-hoc analysis of the IMPALA clinical trial for its respiratory drug molgramostim at the CHEST 2026 Annual Meeting. The study evaluated the treatment's effects on aPAP patients with normal or mildly decreased lung diffusion capacity.…more

    $4.26+1.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 8.24After-hours26.08.25 05:08

    ●●●●●●●● ●●●●● ●●●●●●

    Savara announced that its Phase 3 IMPALA-2 clinical trial data will be featured in one oral and two poster presentations at the upcoming ERS Congress. As this is a presentation of academic data without immediate commercial or regulatory milestones, the impact remains neutral.…more

    $4.26+1.31%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →